Sustainable Investing

Health and nutrition

Health and nutrition is a theme that aims to improve the nutritional value of the food and beverages that we consume, led by a global campaign to reduce their sugar content. This aims to improve human health, principally by addressing the consequences of food that contains too much sugar or other additives. In recent decades, too much sugar in food and beverages has led to an epidemic of obesity, diabetes, and heart disease across the western world.


Food quality

Sugar content in food, along with levels of salt, trans fat, saturated fat and additives to improve taste or its shelf life durability, has risen dramatically as processed food has become mainstream. The principal problem with modern processed food is that it doesn’t contain enough fiber, omega-3 fatty acids or the micronutrients essential to maintain health. Instead, it contains too many trans fats, chemical additives and emulsifiers, salt and sugar.

A study in 2015 showed that of the average 600,000 items in the US food supply, 74% have added sugar, and of the 4,000 packaged items regularly on sales, 50% have a salt content that is higher than what doctors recommend be ingested daily. Too much trans fat leads to higher ‘bad’ cholesterol (LDL) and lower ‘good’ cholesterol (HDL), which contributes to heart disease. Improving food quality over all is seen as being essential to maintain human health, and reduce the burden of treatment issues related to poor diet and obesity on overstretched health services.

Creating returns that benefit the world we live in

Excessive sugar consumption over many years is known to be one of the potential causes of diabetes. More than 400 million people in the world now have diabetes, or one in ten of the adult population, while one third of all US adults are obese. The economic costs of obesity are estimated to be USD 2 trillion annually, or nearly 3% of global GDP. Sugar also has a direct link with Covid-19 deaths as one-third of the fatalities had diabetes, and were twice as likely to die within a week of contracting the disease than non-diabetic patients. In 2020, Robeco concluded a three-year engagement program with eight companies in the food and beverage industry that aimed to encourage them to use less sugar in their products.

Animal welfare and the overuse of antibiotics is another problematic issue, and one with which Robeco has engaged to improve standards in the meat and fish supply chains. Factory farming, in which thousands of chickens, pigs or cows are held together in a confined space, is not only harmful to the livestock, but acts as a breeding ground for diseases such as swine flu and avian flu. The extensive use of antibiotics is causing strains of deadly bacteria to become resistant to them, posing a threat to humans. Robeco has extensively engaged with companies in the meat supply chain to replace antibiotics with safer probiotics. These improve gut health in the animals and thereby reduces routine use of antibiotics to prevent diseases.

The overuse of fertilizers and other chemicals in crop production is another cause for concern, since residues of pesticides can remain in the crop once harvested and pass into the food chain. In 2018, Robeco began an engagement program with agrochemical, seed and fertilizer companies on the role they can play in developing yield-enhancing solutions for farmers, with a specific objective to support smallholder farmers.

Let's keep the conversation going

Keep track of fast-moving events in sustainable and quantitative investing, trends and credits with our newsletters.

Don’t miss out
Robeco

Robeco aims to enable its clients to achieve their financial and sustainability goals by providing superior investment returns and solutions.

Important information
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor.


Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States. This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.